Study to evaluate the effect of metformin in the prevention of hyperglycemia in patients with HR positive/HER2 negative advanced breast cancer and PIK3ca mutation treated with alpelisib and endocrine therapy. Metallic studio.
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: MEDICA SCIENTIA INNOVATION RESEARCH, SL
- Phase: III
- Execution start: 23/03/2021
- End of execution: 30/10/2022
- IP: ISABEL BLANCAS LOPEZ-BARAJAS